» Articles » PMID: 20652282

Bone Mineral Density Changes in Pregnancies with Gestational Hypertension: a Longitudinal Study Using Quantitative Ultrasound Measurements

Overview
Date 2010 Jul 24
PMID 20652282
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare the maternal bone mineral density (BMD) changes in gestational hypertensive and normotensive pregnancies using quantitative ultrasound.

Methods: Consecutive patients were recruited from a general obstetric clinic over a period of 9 months. BMD measurements were performed at the os calcis in early pregnancy before 20 weeks and in the late third trimester after 36 weeks, using a Hologic Sahara Clinical Bone Sonometer system. These patients were followed up in accordance with standard antenatal protocol. The diagnosis of gestational hypertension (GH) was made based on a standard institutional protocol. The changes in BMD from early to late pregnancy were compared between those with/without GH.

Results: A total of 450 patients with complete data were analyzed. The overall incidence of GH was 4.8% (n = 22), of which 1.7% (n = 8) fulfilled the definitions of severe pre-eclampsia. A mean BMD loss of 0.0382 g/cm2 (around 6% of early pregnancy BMD) [corrected] was demonstrable from early to late gestation The hypertensive group has marginally higher mean BMD loss as compared to the normotensive group (0.052 vs. 0.037 g/cm²; P = 0.037). However, regression analysis models showed that early pregnancy BMD values, early pregnancy fat percentage and fat accumulation in pregnancy were significant factors affecting BMD loss during pregnancy, while GH was not in the equations.

Conclusion: The development of gestational hypertensive disorders apparently does not have any significant impact on BMD changes during pregnancy.

Citing Articles

Clinical Devices for Bone Assessment.

Raum K, Laugier P Adv Exp Med Biol. 2022; 1364:35-53.

PMID: 35508870 DOI: 10.1007/978-3-030-91979-5_3.


Inorganic Phosphate in the Pathogenesis of Pregnancy-Related Complications.

Correia-Branco A, Rincon M, Pereira L, Wallingford M Int J Mol Sci. 2020; 21(15).

PMID: 32722465 PMC: 7432618. DOI: 10.3390/ijms21155283.


Pregnancy history, coronary artery calcification and bone mineral density in menopausal women.

Beckman J, Camp J, Lahr B, Bailey K, Kearns A, Garovic V Climacteric. 2017; 21(1):53-59.

PMID: 29189095 PMC: 5759324. DOI: 10.1080/13697137.2017.1406910.


Clinical Evaluation of Bone Strength and Fracture Risk.

de Bakker C, Tseng W, Li Y, Zhao H, Liu X Curr Osteoporos Rep. 2017; 15(1):32-42.

PMID: 28185216 DOI: 10.1007/s11914-017-0346-3.

References
1.
Sowers M, Scholl T, Grewal J, Chen X, Jannausch M . IGF-I, osteocalcin, and bone change in pregnant normotensive and pre-eclamptic women. J Clin Endocrinol Metab. 2001; 86(12):5898-903. DOI: 10.1210/jcem.86.12.8114. View

2.
Olausson H, Laskey M, Goldberg G, Prentice A . Changes in bone mineral status and bone size during pregnancy and the influences of body weight and calcium intake. Am J Clin Nutr. 2008; 88(4):1032-9. DOI: 10.1093/ajcn/88.4.1032. View

3.
Kaur M, Pearson D, Godber I, Lawson N, Baker P, Hosking D . Longitudinal changes in bone mineral density during normal pregnancy. Bone. 2003; 32(4):449-54. DOI: 10.1016/s8756-3282(03)00017-6. View

4.
Pluskiewicz W, Drozdzowska B, Stolecki M . Quantitative ultrasound at the hand phalanges in pregnancy: a longitudinal study. Ultrasound Med Biol. 2004; 30(10):1373-8. DOI: 10.1016/j.ultrasmedbio.2004.08.013. View

5.
Patel R, Blake G, Rymer J, Fogelman I . Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women. Osteoporos Int. 2000; 11(1):68-75. DOI: 10.1007/s001980050008. View